Aspartoacylase (ASPA) Peptid
ASPA
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939419
Kurzübersicht für Aspartoacylase (ASPA) Peptid (ABIN939419)
Target
ASPA
(Aspartoacylase (ASPA))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- IKTSLAPLPC YVYLIEHPSL KYATTRSIAK YPVGIEVGPQ PQGVLRADIL
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ASPA antibody,
Alternative Names: ASPA control peptide, ASPA antibody Blocking Peptide, Anti-ASPA Blocking Peptide, Aspartoacylase Blocking Peptide, Canavan Disease Blocking Peptide, ACY2 Blocking Peptide, ASP Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- ASPA (Aspartoacylase (ASPA))
-
Hintergrund
- ASPA catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids.
-
Molekulargewicht
- 36 kDa
Target
-
Sie sind hier:
